Species and Sex-Dependent Toxicokinetics of 1-Bromopropane: The Role of Hepatic Cytochrome P450 Oxidation and Glutathione (GSH)
-
2014/07/01
Details
-
Personal Author:
-
Description:1. The objectives of the current studies were to evaluate the factors influencing the toxicokinetics of 1-bromopropane (1-BP) in rodents after intravenous (IV) and inhalation exposure. 2. F-344 rats were administered 1-BP via IV bolus injection at 5 and 20 mg/kg and blood concentration determined versus time. F-344 rats and B6C3F1 mice were also exposed to starting inhalation concentrations 70, 240, 800 and 2700 ppm 1-BP in a closed gas uptake system and chamber 1-BP levels were monitored for 6 h. Plasma bromide concentrations were determined to estimate total metabolized dose. Rats were pretreated with chemical inhibitors of cytochrome P450 and glutathione (GSH) synthesis, prior to exposure to 1-BP at 800 ppm within inhalation chambers. 3. Systemic clearance of 1-BP in rat was rapid and decreased with increasing dose. As inhalation chamber concentration of 1-BP increased, the terminal elimination rates decreased. Half-life of 1-BP in rats following inhibition of P450 (9.6 h) or depletion of GSH (4.1 h) increased relative to controls (2.0 h) at 800 ppm. The percentage of 1-BP metabolized decreased with increasing inhalation exposure. Hepatic levels of GSH were significantly lowered regardless of the exposure level in both rats and mice. Chamber concentration-time curves were fit to a two compartment model which was used to estimate metabolic rate constants. 4. These data suggest that in rat, 1-BP clearance is saturable and that elimination is highly dependent on both P450 and GSH-dependent metabolism. This investigation in rodents may provide an understanding of interspecies differences in toxicokinetics and eventually aid translation of animal studies to human risk assessment. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0049-8254
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:44
-
Issue:7
-
NIOSHTIC Number:nn:20053962
-
Citation:Xenobiotica 2014 Jul; 44(7):644-656
-
Contact Point Address:C. Edwin Garner, Metabolism and Pharmacokinetics, Lovelace Respiratory Research Institute, Albuquerque, New Mexico, USA
-
Email:Halifax_garner@yahoo.com
-
CAS Registry Number:
-
Federal Fiscal Year:2014
-
Performing Organization:University of Georgia, Athens
-
Peer Reviewed:True
-
Start Date:20130901
-
Source Full Name:Xenobiotica
-
End Date:20160831
-
Collection(s):
-
Main Document Checksum:urn:sha-512:51b4c70c58d066bd117af3a9d015a44ea5fbc2845d2b7eccefe2076edf9d0a1e595fd333cd63cfff7446bbe0cbc3800a48cc018640c41b1f24e98461e604b0f1
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like